-
"Stress for success”: Unlocking Venetoclax sensitivity in T-ALL through the mTORC1–ISR–BMF axis. by Prof. Vincenzo Ciminale, MD, Istituto Oncologico Veneto, Padova, Italy When: Thursday, 13.11.2025, 14.30–15.30 Where: Aud. 4, BBB Host: Bjørn Tore Gjertsen Abstract Refractory/relapsed T-cell acute lymphoblastic leukemia (R/R T-ALL) remains a major therapeutic challenge at present. Our recent studies showed that inhibition of mTORC1 markedly sensitizes READ MORE
